While hormone replacement therapy (HRT) is not broadly linked to young-onset breast cancer, using certain types before menopause could increase the risk of it developing in young women, a new study suggests.
An international team of researchers found that overall, the use of HRT – a treatment commonly used to alleviate menopause symptoms – was not connected to young-onset breast cancer. Then they looked at the specific type used.
